ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 28 filers reported holding ARGOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 7,526 | +6.7% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 7,054 | +12.8% | 0.00% | – |
| Q2 2017 | $2,000 | -99.4% | 6,256 | -99.2% | 0.00% | – |
| Q1 2017 | $360,000 | +11900.0% | 795,101 | +149074.7% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 533 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 533 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | – | 533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| STATE STREET CORP | 184,194 | $82,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 398 | $0 | 0.00% |